Perceptive Capital Solutions Corp is a blank check company formed to effect a business combination with one or more operating businesses. The company has no ongoing operations and its primary purpose is to identify and acquire a target in the healthcare or healthcare‑related sectors, with a focus on life sciences and medical technology firms in North America or Europe. It was incorporated as a Cayman Islands exempted company and completed its initial public offering in June 2024, placing the proceeds in a trust account for use in a future combination.

Perceptive Capital Solutions Corp has not generated any operating revenues to date and does not expect to do so until it completes its initial business combination. After a combination, revenue will be derived from the operations of the acquired business, which the company anticipates will be in the healthcare industry, providing products or services such as therapeutic development, diagnostic tools, or medical technology solutions to healthcare providers, patients, and related stakeholders.

Within the special purpose acquisition company landscape, Perceptive Capital Solutions Corp competes with numerous other blank check entities seeking business combinations. Its competitive advantage stems from the sponsorship of Perceptive Advisors, a life sciences focused investment firm with over $9.5 billion in assets under management, and the prior experience of its management team in completing several healthcare‑focused SPAC transactions, including ARYA Sciences Acquisition Corp and its successors. This background provides the company with deep industry relationships and a reputation that can attract suitable target businesses in the life sciences and medical technology sectors.

As a pre‑combination blank check company, Perceptive Capital Solutions Corp does not presently serve any customers. Following a successful business combination, the company will inherit the customer base of the acquired target, which is expected to consist of hospitals, clinics, pharmaceutical companies, research institutions, and patients seeking innovative healthcare solutions within the life sciences and medical technology fields.